Andreas Wollenberg is an expert in Dermatology at University Hospital Augsburg (Germany). As of October 2026, ScienceLeadR ranks Andreas Wollenberg in the top 1% of experts worldwide for Dermatitis, Hypersensitivity and Sexually Transmitted Diseases. Andreas Wollenberg has authored 544 publications, the most recent in 2026, and is an investigator in 26 clinical trials, 4 of them ongoing. SLR score: 2,431 (community average: 125). How the SLR is computed.

LeadR Profile

Andreas Wollenberg University Hospital Augsburg Germany
2 431 ScienceLeadR Reputation 2431
Network Map

Dermatology

Subspecialties: Immunology - Genetics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Prof. Dr. med. Dr. h.c. Andreas Wollenberg

University Hospital Augsburg, Augsburg, Germany

Andreas Wollenberg is a Professor of Dermatology and Allergy, working at the University Hospital Augsburg, Germany. In addition, he is teaching at the Ludwig-Maximilian University in Munich, Germany. Moreover, he is affiliated with the Comprehensive Center for Inflammatory Medicine at the University Hospital Lübeck, Germany. Prof. Wollenberg completed his internship and residency at Ludwig-Maximilian University in Munich and subsequently trained at The Scripps Research Institute in La Jolla, California, USA.

Prof. Andreas Wollenberg has conducted research in the field of atopic dermatitis, experimental dermatology, dendritic cell research, eczema herpeticum, perioral dermatitis and EGFR-inhibitor-induced skin toxicity. His research has generated more than 410 peer-reviewed publications and a Hirsch Index of 81. He has described and characterized the inflammatory dendritic epidermal cells, as well as the cutaneous plasmacytoid dendritic cells, and has coined the concept of proactive therapy.

Currently, he is a member of the editorial board of the Journal of the European Academy of Dermatology and Venerology, and a reviewer for many biomedical journals. Prof. Wollenberg has served for 10 years as head of the European Task Force on Atopic Dermatitis (ETFAD) and has authored the ETFAD Position Paper on AD management. Moreover, he is the lead author of the current EuroGuiDerm Guidelines for Atopic Dermatitis. Prof. Wollenberg is executive board member and Secretary of the International Society of Atopic Dermatitis (ISAD). He received a Dr. honoris causae from the Medical University Iuliu Hatieganu in Cluj-Napoca.

Organizations

Career arc: 1989 - 2026

Source: PubMed

University Hospital Augsburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 544

Citations

Citations: 23 423 1st author: 114 Last author: 123 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.
PMID 42628554 — injections, safety, dermatitis, injection site reaction, drug-related side effects and adverse reactions, therapeutics, dermatitis, atopic
Lancet Top journal20263
Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper.
PMID 42578759 — sexually transmitted diseases, dermatitis, work, therapeutics, dermatology, dermatitis, atopic
Acta Derm Venereol20260
Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
PMID 42549932 — dermatitis, therapeutics, dermatitis, atopic
J Dermatolog Treat20260
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial.
PMID 42473690 — sexually transmitted diseases, quality of life, dermatitis, skin diseases, signs and symptoms, drug-related side effects and adverse reactions, pruritus, therapeutics, pharmaceutical vehicles, dermatitis, atopic
J Eur Acad Dermatol Venereol20260
Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.
PMID 42413573 — registries, skin, genes, genes, rrna, dermatitis, therapeutics, dermatology, child, dermatitis, atopic
J Invest Dermatol20261

Clinical Studies 26

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 15
Phase 2 9
N/A 1
Phase 2/Phase 3 1

By status:

Completed 21
Recruiting 3
Active not recruiting 1
Unknown 1

By type:

Interventional 25
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 24

Main Topics

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Phase 3 Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic Dermographism
2025-522583-32-00 — urticaria, cold temperature, multiple chronic conditions, therapeutics
Phase 3Recruiting2026
A Study to Evaluate the Long term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
2024-519795-11-00 — safety, dermatitis, dermatitis, atopic
Phase 2Recruiting2025
Intervention With Tralokinumab in Patients With Moderate to severe Atopic Dermatitis With Genital Impact
NCT07444801 — microscopy, confocal, dermatitis, tomography, immunoglobulin a, microscopy, tomography, optical coherence, therapeutics, dermatitis, atopic
N/ARecruiting2025
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate to Severe Atopic Dermatitis
NCT06136741 — injections, gtp-binding proteins, safety, dermatitis, pharmaceutical preparations, solutions, rhoa gtp-binding protein, therapeutics, guanosine triphosphate, dermatitis, atopic
Phase 2Active not recruiting2023

LeadR Networks

Main global connection map